GENEVA, SWITZERLAND – GenevaLunch is on a slow-news holiday schedule for the next two weeks, but to make sure you don’t miss key reports we’re bringing you highlights from some of the news beats, with links to original sources: EPFL plays key role in understanding Deepwater Horizon oil spill EPFL is playing a key role [...]
Roche earnings down 5% in 2008, shares take biggest dive in 11 years
February 4, 2009 by
Basel, Switzerland (GenevaLunch) – Markets reacted with disappointment to Pharmaceutical giant Roche’s 2008 results, published 4 February. The group’s earnings fell by 5% due to a strong Swiss franc and lower net financial income, despite group sales rising by 10% in local currencies and group profits up 4% in local currencies, to CHF13.9 billion.
Roche behind forecast but still growing
October 21, 2008 by
Basel, Switzerland (GenevaLunch) – Basel-based Roche Holdings AG, the number two Swiss pharmaceutical company announced sales growth for Q3, although lower than forecasts, due to a decline in sales of the pandemic Tamiflu vaccine.
